These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22934452)

  • 1. Triple immunosuppressive therapy can accelerate the recovery of antibody-mediated pure red cell aplasia and allow successful concurrent resumption of erythropoietin.
    Ruangkanchanasetr P; Srichaikul T; Supaporn T
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S92-5. PubMed ID: 22934452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-mediated pure red cell aplasia related with epoetin-beta pegol (C.E.R.A.) as an erythropoietic agent: case report of a dialysis patient.
    Shingu Y; Nakata T; Sawai S; Tanaka H; Asai O; Tamagaki K; Nakatani K
    BMC Nephrol; 2020 Jul; 21(1):275. PubMed ID: 32664894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of anti-erythropoietin antibody-mediated pure red cell aplasia with low-dose prednisolone.
    Aoki K; Ono Y; Tabata S; Matsushita A; Ishikawa T
    Int J Hematol; 2013 Feb; 97(2):272-4. PubMed ID: 23355260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-mediated pure red-cell aplasia (PRCA): the Spanish experience.
    Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; de Francisco AL; Aljama P;
    J Nephrol; 2005; 18(4):382-7. PubMed ID: 16245241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of epoetin-induced pure red cell aplasia 2 years later, successful re-challenge with continuous erythropoiesis receptor stimulator.
    Lim SK; Bee PC; Keng TC; Chong YB
    Clin Nephrol; 2013 Sep; 80(3):227-30. PubMed ID: 23298519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful reintroduction of a different erythropoiesis-stimulating agent after pure red cell aplasia: relapse after successful therapy with prednisone.
    Andrade J; Taylor PA; Love JM; Levin A
    Nephrol Dial Transplant; 2005 Nov; 20(11):2548-51. PubMed ID: 16046510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure red cell aplasia induced only by intravenous administration of recombinant human erythropoietin.
    Shimizu H; Saitoh T; Ota F; Jimbo T; Tsukada Y; Murakami H; Nojima Y
    Acta Haematol; 2011; 126(2):114-8. PubMed ID: 21654161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 46-Year-Old Thai Woman with Secondary Acquired Pure Red Cell Aplasia Due to Treatment with Recombinant Erythropoietin While on Dialysis for End-Stage Renal Disease Who Recovered Following ABO-Incompatible Kidney Transplantation.
    Kitpermkiat R; Thotsiri S; Arpornsujaritkun N; Sangkum P; Chantrathammachart P; Kitpoka P; Thammanichanond D; Virankabutra T; Kantachuvesiri S
    Am J Case Rep; 2022 Jul; 23():e935451. PubMed ID: 35842751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin-induced, antibody-mediated pure red cell aplasia.
    Rossert J;
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():95-9. PubMed ID: 16281965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible complications of erythropoietin therapy in patients with chronic renal failure].
    Pljesa S
    Med Pregl; 2004; 57(5-6):254-7. PubMed ID: 15503795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity syndrome and pure red cell aplasia following allopurinol therapy in a patient with chronic kidney disease.
    Chao SC; Yang CC; Lee JY
    Ann Pharmacother; 2005 Sep; 39(9):1552-6. PubMed ID: 16076905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-control study of the association between select HLA genes and anti-erythropoietin antibody-positive pure red-cell aplasia.
    Fijal B; Ricci D; Vercammen E; Palmer PA; Fotiou F; Fife D; Lindholm A; Broderick E; Francke S; Wu X; Colaianne J; Cohen N
    Pharmacogenomics; 2008 Feb; 9(2):157-67. PubMed ID: 18370845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rechallenge with intravenous recombinant human erythropoietin can be successful following the treatment of anti-recombinant erythropoietin associated pure red cell aplasia.
    Praditpornsilpa K; Tiranathanakul K; Jootar S; Tungsanga K; Eiam-Ong S
    Clin Nephrol; 2014 May; 81(5):355-8. PubMed ID: 23110772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk.
    Cournoyer D; Toffelmire EB; Wells GA; Barber DL; Barrett BJ; Delage R; Forrest DL; Gagnon RF; Harvey EA; Laneuville P; Patterson BJ; Poon MC; Posen GA; Messner HA;
    J Am Soc Nephrol; 2004 Oct; 15(10):2728-34. PubMed ID: 15466278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early onset of anti- erythropoietin antibody-mediated pure red cell aplasia after commencement of subcutaneous administration of epoetin-β].
    Tanaka A; Tsukada J; Morimoto H; Katsuragi T; Nakanishi T; Watanabe S; Hirase N; Motomura S
    Rinsho Ketsueki; 2012 Jan; 53(1):110-2. PubMed ID: 22374534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
    Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML
    Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of pure red-cell aplasia secondary to antierythropoietin antibodies after cessation of recombinant human erythropoietin.
    Panchapakesan U; Austin SK; Shafransky A; Lawrence JA; Savdie E
    Intern Med J; 2003; 33(9-10):468-71. PubMed ID: 14511202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of erythropoietin-associated pure red cell aplasia.
    Carson KR; Evens AM; Bennett CL; Luminari S
    Best Pract Res Clin Haematol; 2005; 18(3):467-72. PubMed ID: 15792921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin.
    Casadevall N
    Nephrol Dial Transplant; 2003 Nov; 18 Suppl 8():viii37-41. PubMed ID: 14608000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful resumption of epoetin alfa after rituximab treatment in a patient with pure red cell aplasia.
    Mandreoli M; Finelli C; Lopez A; Ascani S; Vianelli N; Baccarani M; Santoro A
    Am J Kidney Dis; 2004 Oct; 44(4):757-61. PubMed ID: 15384028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.